UP!
| Period | Date | Adjusted Actuals EPS | GAAP EPS |
|---|---|---|---|
| Q3 2022 | 2022-11-07 | Future report Set alerts | |
| Q2 2022 | 2022-08-03 | -3.18 | -3.18 |
| Q1 2022 | 2022-05-04 | -3.40 | -3.40 |
| Q4 2021 | 2022-02-28 | -3.72 | -3.72 |
| Q3 2021 | 2021-11-08 | -1.55 | -1.55 |
| Q2 2021 | 2021-08-05 | -3.23 | -3.23 |
| Q1 2021 | 2021-05-06 | -2.67 | -2.67 |
| Q4 2020 | 2021-02-25 | -2.08 | -2.08 |
| Q3 2020 | 2020-11-02 | 0.00 | 0.00 |
| Q2 2020 | 2020-08-06 | -1.89 | -1.89 |
| 2016-06-06 | Lower Price Target | Barclays | Overweight | $41.00 to $27.00 |
| 2016-06-06 | Downgrade | Leerink Swann | Outperform to Market Perform | $37.00 to $20.00 |
| 2016-06-06 | Lower Price Target | Citigroup Inc. | Buy | $30.00 to $23.00 |
| 2016-06-06 | Downgrade | Jefferies Group | Buy to Hold | $27.00 to $17.00 |
| 2016-06-06 | Lower Price Target | Wedbush | Outperform | $29.00 to $27.00 |
| 2016-06-06 | Lower Price Target | Barclays PLC | Overweight | $41.00 to $27.00 |
| 2016-05-24 | Reiterated Rating | Wedbush | Outperform | $41.00 to $29.00 |
| 2016-05-12 | Initiated Coverage | Piper Jaffray | Hold | $20.00 to $17.00 |
| 2016-05-12 | Initiated Coverage | Piper Jaffray Cos. | Hold | $20.00 to $17.00 |
| 2016-05-09 | Reiterated Rating | Jefferies Group | Buy | $29.00 to $27.00 |
| 2016-05-06 | Reiterated Rating | Wedbush | Outperform | $45.00 to $41.00 |
| 2016-05-06 | Upgrade | Avondale Partners | Market Perform to Market Outperform | $22.00 to $20.00 |
| 2016-03-10 | Reiterated Rating | Wedbush | Outperform | $45.00 |
| 2016-03-10 | Lower Price Target | Leerink Swann | Outperform | $50.00 to $37.00 |
| 2016-03-10 | Lower Price Target | Jefferies Group | Buy | $33.00 to $29.00 |
| 2016-03-01 | Initiated Coverage | SunTrust | Buy | $32.00 |
| 2016-03-01 | Initiated Coverage | SunTrust Banks Inc. | Buy | $32.00 |
| 2016-02-24 | Lower Price Target | Barclays | Buy | $50.00 to $41.00 |
| 2016-02-19 | Lower Price Target | Citigroup Inc. | $48.00 to $34.00 | |
| 2016-02-17 | Reiterated Rating | Jefferies | Buy | $43.00 to $33.00 |
| 2016-02-17 | Initiated Coverage | Jefferies Group | Buy | |
| 2016-01-13 | Upgrade | Citigroup Inc. | Neutral to Buy | $48.00 |
| 2015-11-23 | Initiated Coverage | Citigroup Inc. | Neutral | |
| 2015-10-19 | Initiated Coverage | Barclays | Overweight | $50.00 to $50.00 |
| 2015-09-17 | Downgrade | Piper Jaffray | Overweight to Neutral | $50.00 to $45.00 |
| 2015-09-11 | Reiterated Rating | Wedbush | Outperform | $45.00 |
| 2015-09-10 | Reiterated Rating | Leerink Swann | Outperform | $35.00 to $50.00 |
| 2015-06-02 | Reiterated Rating | Piper Jaffray | Overweight | $37.00 to $50.00 |
| 2015-06-02 | Reiterated Rating | Jefferies Group | Buy | $34.00 to $43.00 |
| 2015-06-01 | Boost Price Target | Wedbush | Outperform | $34.00 to $45.00 |
| 2015-06-01 | Downgrade | Brean Capital | Buy to Hold | |
| 2015-05-29 | Initiated Coverage | Citigroup Inc. | Buy | $45.00 |
| 2015-05-08 | Boost Price Target | Leerink Swann | Outperform | $27.00 to $35.00 |
| 2015-05-08 | Boost Price Target | Brean Capital | Buy | $27.00 to $34.00 |
| 2015-03-27 | Initiated Coverage | Jefferies Group | Buy | $34.00 |
| 2015-03-12 | Boost Price Target | Leerink Swann | Outperform | $25.00 to $27.00 |
| 2014-12-22 | Boost Price Target | Piper Jaffray | Overweight | $31.00 to $37.00 |
| 2014-09-18 | Initiated Coverage | Wedbush | Outperform | $29.00 |
| 2014-07-11 | Upgrade | Johnson Rice | Overweight to Focus List | |
| 2014-07-08 | Initiated Coverage | Brean Capital | Buy | $27.00 |
| 2014-06-16 | Reiterated Rating | JMP Securities | Market Outperform | $25.00 to $28.00 |
| 2014-03-18 | Boost Price Target | Brean Capital | Buy | $20.00 to $27.00 |
| 2014-03-04 | Lower Price Target | Jefferies Group | $36.00 to $34.00 | |
| 2013-12-18 | Initiated Coverage | Jefferies Group | Buy | $36.00 |
| 2013-11-14 | Boost Price Target | JMP Securities | Market Outperform | $19.00 to $25.00 |
| 2013-11-04 | Initiated Coverage | Leerink Swann | Outperform |
| 2016-06-06 | Lower Price Target | Barclays | Overweight | $41.00 to $27.00 |
| 2016-06-06 | Downgrade | Leerink Swann | Outperform to Market Perform | $37.00 to $20.00 |
| 2016-06-06 | Lower Price Target | Citigroup Inc. | Buy | $30.00 to $23.00 |
| 2016-06-06 | Downgrade | Jefferies Group | Buy to Hold | $27.00 to $17.00 |
| 2016-06-06 | Lower Price Target | Wedbush | Outperform | $29.00 to $27.00 |
There is presents forecasts of rating agencies and recommendations for investors about this ticker
In MRTX 176 funds of 2213 total. Show all
| Fund name | Ticker shares |
|---|---|
| venBio Select Advisor LLC | 5.55M |
| Vanguard Group, Inc | 4.73M |
| WELLINGTON MANAGEMENT CO LLP | 3.47M |
| PERCEPTIVE ADVISORS LLC | 2.78M |
| GOLDMAN SACHS GROUP INC | 2.45M |
| BlackRock Inc. | 2.43M |
| FMR LLC | 2.14M |
| Camber Capital Management LLC | 2.00M |
| Boxer Capital, LLC | 2.00M |
| ARMISTICE CAPITAL, LLC | 1.90M |
| RTW INVESTMENTS, LLC | 1.88M |
| STATE STREET CORP | 1.57M |
| AMERIPRISE FINANCIAL INC | 1.47M |
| FRANKLIN RESOURCES INC | 1.46M |
| ORBIMED ADVISORS LLC | 1.42M |
| Name Relationship | Total Shares | Holding stocks |
|---|---|---|
| venBio Select Advisor LLC | 32.50% (4398101) | IMMU / MRTX / |
| Boxer Capital, LLC | 23.17% (3135966) | EBIO / MRTX / ODT / |
| Braslyn Ltd. | 21.28% (2880702) | MRTX / |
| Broadfin Healthcare Master Fund Ltd | 20.16% (2728601) | AEGR / FLML / MELA / MRTX / PETX / PGNX / QLTI / REPH / |
| ORBIMED ADVISORS LLC | 9.36% (1267000) | AGLE / AMBI / ANTH / ATHX / BOLD / BONE / CRVS / CTIC / ICPT / KALA / LOXO / MRTX / OTIC / RLYP / ROKA / SIEN / SUPN / SYBX / XLRN / |
| TANG CAPITAL PARTNERS LP | 9.15% (1238543) | MRTX / |
| BAKER BROS. ADVISORS LP | 1.04% (141244) | ACAD / AQXP / BCRX / GHDX / IDRA / INCY / MRTX / SGEN / XOMA / |
| BAUM CHARLES M President and CEO | 0.38% (50932) | ARRY / MRTX / |
| BAKER FELIX | 0.30% (40308) | ACAD / BCRX / GEVA / GHDX / MRTX / SGEN / |
| CHEN ISAN Chief Medical & Dev\'t Officer | 0.24% (31836) | MRTX / |
| Gergen Mark J Exec. VP and COO | 0.04% (5748) | HALO / MRTX / |
| Christensen Jamie SVP & Chief Scientific Officer | 0.02% (2877) | MRTX / |
UM